Related Experiment Videos
Liver transplantation in acute liver failure
1Department of Internal Medicine, Division of Gastroenterology, University of Michigan Medical School, Ann Arbor, MI, USA.
Panminerva Medica
|July 12, 2003
Summary
Acute liver failure, often caused by acetaminophen overdose or drug-induced liver injury, presents significant challenges. Management in specialized centers with liver transplantation access is crucial for improving survival rates in this critical condition.
Area of Science:
- Hepatology
- Critical Care Medicine
- Transplantation Surgery
Background:
- Acetaminophen overdose and drug-induced liver injury are leading causes of acute liver failure (ALF) in Western countries.
- Infectious complications and cerebral edema are primary causes of mortality in ALF patients.
- Current management strategies for ALF are evolving, with a focus on supportive care and timely interventions.
Purpose of the Study:
- To review current understanding and management of acute liver failure.
- To highlight advancements in treating complications like cerebral edema and coagulopathy.
- To discuss the role of liver transplantation and emerging supportive therapies.
Main Methods:
- Review of current literature on acute liver failure etiologies, complications, and treatments.
- Analysis of prognostic factors and outcomes of liver transplantation for ALF.
- Discussion of preventative measures and optimal patient management strategies.
Main Results:
- Acetaminophen and idiosyncratic drug reactions are common ALF causes; infections and cerebral edema are leading deaths.
- Hypothermia and factor VIIa infusions show promise for managing cerebral edema and coagulopathy.
- Liver transplantation survival for ALF is lower than for chronic liver failure due to emergent nature and organ failure.
Conclusions:
- Management of ALF requires experienced centers with liver transplant capabilities.
- Prognostic models incorporating lactate levels may aid in identifying patients needing urgent transplantation.
- Preventative public health measures and optimized medical interventions are key to reducing ALF incidence and improving outcomes.